Patent ID: 11896562
Assignee: ADARE PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 5:
6. The method of claim 1, wherein the therapeutically effective amount of racemic amphetamine, or a pharmaceutically acceptable salt or ester thereof in the drug containing core particles is a dose equivalent to 30 mg of racemic amphetamine sulfate, wherein after administration, the orally disintegrating pharmaceutical composition provides two or more of the following:
an AUCinf ranging from about 80% to about 125% of about 400-600 hr*ng/mL;
a Cmax ranging from about 80% to about 125% of about 25-35 ng/mL; or
a Tmax ranging from about 80% to about 125% of about 2-4 hrs.